Beschreibung
InhaltsangabeT cell responses in myeloma.- Novel antigenic targets for immunotherapy in myeloma.- Antibody-based therapies in Multiple Myeloma.- Defining multiple myeloma as a target for DNA gene fusion vaccines.- Harnessing allogeneic immunity for anti-myeloma response.- Dendritic cell and peptide-based vaccination in myeloma.- New Proteasome inhibitors.- Newer Imids.- New agents in myeloma.- Early Combination Studies in MM.- The effect of novel antimyeloma agents on bone metabolism.- Index.
Autorenporträt
InhaltsangabeT cell responses in myeloma.- Novel antigenic targets for immunotherapy in myeloma.- Antibody-based therapies in Multiple Myeloma.- Defining multiple myeloma as a target for DNA gene fusion vaccines.- Harnessing allogeneic immunity for anti-myeloma response.- Dendritic cell and peptide-based vaccination in myeloma.- New Proteasome inhibitors.- Newer Imids.- New agents in myeloma.- Early Combination Studies in MM.- The effect of novel antimyeloma agents on bone metabolism.- Index.